Tel Aviv Stock Exchange Completes Public Stage of Offering
The general public was offered stock worth $6.5 million with a cap of $8,500 per investor. Over 1,000 private investors participated in the public stage, through brokers and bank consultants
Earlier on Monday, Calcalist reported, citing people familiar with the matter who spoke on condition of anonymity, that TASE closed the institutional pricing stage of the 31.7% stake offered with demand outstripping supply by five.
TASE will begin trading at a market capitalization of NIS 710 million (approximately $201.8 million) in August. The exchange will receive about NIS 35 million (approximately $9.4 million) from the sale, half of the additional profit above the original NIS 550 million (approximately $156 million) valuation made by the four funds that acquired recently sold stake in 2018—Australian superannuation fund Sunsuper, Santa Monica-based Dalton Investments LLC, New York-headquartered investment bank Moelis & Company, and Denmark-based Novo Nordisk Foundation.